Prognostic and Predictive Factors Associated With Ipilimumab-Related Adverse Events: A Retrospective Analysis of 11 NCI-sponsored Phase I Clinical Trials
Oncotarget - United States
doi 10.18632/oncotarget.27537
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 21, 2020
Authors
Publisher
Impact Journals, LLC